Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Raubenheimer PJ, Cushman WC, Avezum A, Basile J, Conget I, Dagenais G, Hoover A, Jansky P, Lanas F, Leiter LA, Lopez-Jaramillo P, Pogosova N, Probstfield J, Rao-Melacini P, Rydén L, Sheu WH, Temelkova-Kurktschiev T, C Gerstein H.
Raubenheimer PJ, et al. Among authors: hoover a.
Diabetes Obes Metab. 2022 Apr;24(4):704-712. doi: 10.1111/dom.14634. Epub 2022 Jan 24.
Diabetes Obes Metab. 2022.
PMID: 34984808
Clinical Trial.